1Bureh HB. Graves ophthalmopathy: current concepts regarding pathogenesis and management [J ]. Endocr Rev, 1993, 14: 747-793.
2Tallstedt L. Surgical treatment of thyroid eye disease[J ]. Thyroid, 1998, 8(5) :447-452.
3McCord CD. Current trends in orbital decompression [ J ]. Ophthalmology, 1985, 92(1) :21-23.
4Safa AM. Long- term follow - up results in children and adolescents treated with radioactive iodine(^131 Ⅰ )for hyperthyroidism[J]. N Engl J Med, 1975, 292:167-171.
5Dobyns BM. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow - up stuy [ J ]. J Chin Endocrinol Metab, 1974, 38:976-998.
6Bartalena L. Manageinent of Graves ophthalmopathy: Reality and Perspectives[J]. Endocr Rev, 2002, 21 : 168-199.
7Mengistu M, Largen E, Miller A, et al. Clinical significance of a new autoantibody agaist human eye muscle soluble autigen, detected by immunofluorescence[J]. Clin Exp Immunol, 1986, 65 :19.
